$DAR

Darling Ingredients (DAR) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Randall C. Stuewe Chief Financial Officer - Bob Day Senior Vice President of Investor Relations - Suann Guthrie Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Net Income -- $387 million, or $2.41 per GAAP diluted share, compared to $13 million, or $0.08 per share in the prior year, reflecting improved global operations and margin expansion.

Original reporting
Published Jul 31, 2026, 3:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Darling Ingredients (DAR) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$DARBullishMed
01

Why it matters

Key new trading inputs are the Q3 Core Ingredients EBITDA guidance range, DGD EBITDA per gallon, debt paydown and year-end leverage target, and specific portfolio actions (Brazil rendering facilities acquisition, trap business divestiture, European casings sale agreement). These collectively affect valuation through cash-flow durability and balance-sheet risk.

02

Market read

The call provides concrete forward guidance and balance-sheet targets that can drive near-term positioning in DAR around earnings expectations and leverage risk.

03

What to watch

The transcript emphasizes recoveries and favorable conditions; traders should separately assess sustainability of margins in collagen/health ingredients and execution risk on capacity additions and the European casings sale timeline.

Relevance 8/10Novelty 7/10Timing: earnings call transcript for Q2 2026, published pre-market July 31

Background

Darling Ingredients held its Q2 2026 earnings call, discussing earnings power, specialty product strategy, Diamond Green Diesel (DGD) renewable fuel performance, and capital allocation.

Company-level read

Ticker impact

$DARBullishMedium confidence
Context

Darling reported Q2 2026 results and guided Q3 Core Ingredients EBITDA to $325 million to $340 million, plus debt leverage targets below 2.0x.

Expected impact

Likely positive bias for DAR as traders price in improved margins, lower leverage, and accretive acquisitions/divestitures.

Evidence & confidence

The article discloses multiple decision-relevant datapoints: Q2 net income and sales inflection, explicit Q3 EBITDA guidance, debt paydown and year-end target, and specific capital allocation (buybacks, capex, acquisition, divestiture). These are actionable for positioning, though the transcript format may limit incremental surprise versus the earnings release.

Market effects

Signals continued margin shift toward specialty collagen/health ingredients and ongoing optimization of rendering and renewable fuel operations.

China capacity expansion (Kaiping spray dryer) and Brazil rendering acquisitions highlight continued investment in Asia and South America supply chains.

DGD production and RIN tightness commentary ties performance to U.S. renewable fuel compliance dynamics and global feedstock/feedstock-cost volatility.

Counterpoint

Guidance and leverage targets may be sensitive to renewable fuel spreads, RIN tightness, and feedstock pricing; tariff recoveries and recoveries could be non-recurring.

Key entities

  • Darling Ingredients Inc.

    Reported Q2 2026 results, provided Q3 EBITDA guidance, and outlined debt reduction and portfolio simplification plans.

  • Diamond Green Diesel

    Renewable fuel joint venture whose EBITDA per gallon, production run rates, and tariff recovery were discussed.

  • Nextida

    Specialty collagen glucose control products discussed as expanding into Asian markets.

Related articles

$DARMedAI 8/10

Darling Ingredients Q2 net income surges to $387M

Darling Ingredients reported a surge in second-quarter net income to $387.3 million from $12.7 million a year ago, though sales rose but slightly missed analyst expectations, according to Reuters. The animal-based ingredients producer repurchased $73 million in stock and reduced net debt by $223 million during the quarter. For the third quarter, the company estimates core ingredients adjusted EBITDA of $325 million to $340 million.

$DARMed

Darling Ingredients Inc. Q2 2026 Earnings Call Summary

Darling Ingredients (DAR) reported Q2 2026 outperformance driven by higher fat and protein prices, strong biofuel demand, and tighter fish meal supplies. Management cited operational initiatives targeting $150m-$300m extra EBITDA over three years. Q3 Core Ingredients EBITDA guidance is $325m-$340m, with net debt below $3b by year-end 2026.

$DARHigh

DARLING INGREDIENTS INC. (DAR): Results of Operations and Financial Condition

DARLING INGREDIENTS INC. (DAR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh991-pressreleaseq22026.htm EX-99.1 PRESS RELEASE Document Exhibit 99.1 FOR IMMEDIATE RELEASE July 30, 2026 Darling Ingredients Inc. Reports Second Quarter 2026 Results • Net income of $387.3 million, or $2.41 per GAAP diluted share, compared to net income of $12.7 mi

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.